In Motion sickness Motion sickness is a condition caused due to motion during travel. You may experience dizziness, nausea or vomiting as a result of this condition. Diligan 25 Tablet helps treat these symptoms effectively. Take it as prescribed by the doctor to get maximum benefit. In Vertigo Vertigo means a spinning sensation or dizziness that is triggered due to frequent movement. It can happen due to many reasons but it may also occur without any underlying disease. Diligan 25 Tablet helps treat this sensation effectively. If you feel dizzy while getting up from the bed, sit for a while and then rise slowly to avoid having an accidental fall.
Diligan 25 Tablet may cause excessive drowsiness with alcohol.
Diligan 25 Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Diligan 25 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. Larger doses or prolonged use of Diligan 25 Tablet may cause sleepiness and other effects in the baby
Diligan 25 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
There is limited information available on the use of Diligan 25 Tablet in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of Diligan 25 Tablet in patients with liver disease. Please consult your doctor.
If you miss a dose of Diligan 25 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Gladstone Pharma India Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Yash Pharma Laboratories Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Colinz Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sanmai Pharma || ₹14.5/tablet (25% cheaper)